Purchases and Sales Made in Q1 2022 in Unity Biotechnology, Inc. (UBX)
This table provides information about the institutional ownership of Unity Biotechnology, Inc. (UBX) during Q1 2022. The information is specifically focused on institutions that hold shares of Unity Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2022
Q1 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-47.9KClosed |
$34.5K - $89K
|
0
$0
|
|
|
May 12, 2022
Q1 2022
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-60.4K- 64.03% |
$43.5K - $112K
|
33.9K
$72.6K
|
|
|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-67K- 74.27% |
$48.2K - $125K
|
23.2K
$49.6K
|
|
|
May 02, 2022
Q1 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-71.6K- 78.43% |
$51.6K - $133K
|
19.7K
$42.2K
|
|
|
May 16, 2022
Q1 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-164K- 46.62% |
$118K - $305K
|
188K
$402K
|
|
|
May 13, 2022
Q1 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-171K- 15.87% |
$123K - $318K
|
907K
$1.94M
|
|
|
May 16, 2022
Q1 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-187K- 35.74% |
$134K - $347K
|
336K
$719K
|
|
|
May 16, 2022
Q1 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-214K- 24.0% |
$154K - $398K
|
678K
$1.45M
|
|
|
May 16, 2022
Q1 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-383K- 73.91% |
$276K - $712K
|
135K
$289K
|
|
|
May 13, 2022
Q1 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-654K- 36.74% |
$471K - $1.22M
|
1.13M
$2.41M
|
|
|
May 16, 2022
Q1 2022
|
Invus Financial Advisors, LLC
New York, NY |
SELL
|
- |
-1.09MClosed |
$788K - $2.04M
|
0
$0
|